期刊文献+

P-GSK3β和β-catenin蛋白在子宫内膜癌中的表达及临床意义 被引量:4

The expression and clinical significance of P-GSK3βandβ-catenin in endometrial carcinoma
下载PDF
导出
摘要 目的检测子宫内膜癌组织中P-GSK3β蛋白和β-catenin蛋白表达并探讨其意义。方法采用微波EliVisionTM免疫组织化学法检测60例子宫内膜癌,32例正常子宫内膜组织中P-GSK3β蛋白和β-catenin蛋白的表达。结果正常子宫内膜组织中β-catenin蛋白表达正常,子宫内膜癌组织中β-catenin发生异位表达。子宫内膜癌组织中P-GSK3β和异位表达的β-catenin分别定位于细胞浆和细胞核,两者表达明显高于癌旁正常组织(P<0.05)。两者的表达与肌层浸润程度、淋巴结转移、临床分期及病理分期有关(P<0.05);两者之间表达呈正相关(P<0.05)。结论 P-GSK3β表达和β-catenin异位表达在子宫内膜癌呈高表达,且与子宫内膜癌的发生、发展和转移密切相关。 Objective To investigate the expression and clinical significance of P-GSK3β and β-catenin in the endometrial carcinoma.Methods The expression levels of P-GSK3βandβ-catenin were detected by microwave EliVisionTM in 60 cases of endometrial cancers and 32 cases of normal endometrial tissues.Results In normal endometrial tissues,the expression of β-catenin protein was normal,however,the ectopic expression of β-catenin protein was observed in endometrial cancers.The expression of P-GSK3β and ectopic expression of β-catenin protein were located in cytoplasm and nucleolus,respectively,and their expression levels were significantly higher than those of the normal tissues beside the cancers (P0.05).Their expression levels were related with myometrial invasion degree,lymph node metastasis,clinical staging and pathological staging (P0.05),and the expression of P-GSK3β was positively correlated with that of β-catenin (P0.05).Conclusion The expression of P-GSK3β and ectopic expression of β-catenin are increased in endometrial carcinoma,which is closely correlated with the pathogenesis,development and metastasis of endometrial carcinoma.
作者 张智慧
出处 《河北医药》 CAS 2012年第14期2091-2093,共3页 Hebei Medical Journal
关键词 子宫内膜肿瘤 P-GSK3β Β-CATENIN 免疫组化 endometrial carcinoma β-catenin P-GSK3β immunohistochemistry
  • 相关文献

参考文献8

  • 1朱光君,熊正文,苏红,李春光,胡海霞.标准型CD44基因蛋白在78例非小细胞肺癌中表达的定量研究[J].中国组织化学与细胞化学杂志,2002,11(2):174-177. 被引量:30
  • 2熊正文,王炳胜,朱光君,苏红,李春光,安赵栓.CD_(34)、CD_(31)与F_(Ⅷ)显示非小细胞肺癌微血管密度的对比研究[J].中国医师杂志,2003,5(4):438-441. 被引量:22
  • 3Frame S,Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J ,2001,359:1-16.
  • 4Kim HS, Skurk C, Thomas SR, et al. Epub 2002 Regulation of angiogene- si by glyeogen synthase kinase-3beta. J Biol Chem,2002,277: 41888-41896.
  • 5Holley $L,Heighway J ,Hoban PR. Induced exp ression of human CCND1 ahemative transcripts in mouse Cyl-1 knockout fibr blasts highlights func- tional differences. Int J Cancer,2005,114:364-370.
  • 6Liang J, Slingerland JM. Multiple roles of the PI3 K/PKB (Akt)pathway in cell cycle progression. Cell Cycle ,2003,2:339-345.
  • 7Rieghoff E, Behrens JB, Mayr B. Nucleo-cytoplasmic distribution ofbetacatenin is regulated by retention. Joumal of Cell Sci, 2006,119:1453- 1463.
  • 8Ban KC, Singh H, Kfishnan R, et al. GSK-3beta phosphorylation and alteration of beta-eatenin in hepatoeelhlar carcinoma. Cancer Lett,2003, 199:201-208.

二级参考文献18

  • 1熊正文,李春光,丁华野,史景泉.肿瘤组织微血管生成及微循环形态学研究技术[J].中国组织化学与细胞化学杂志,1998,7(4):139-140. 被引量:6
  • 2熊正文.免疫组织化学技术中抗原修复的研究进展[J].中华病理学杂志,1997,26(2):124-126. 被引量:74
  • 3Iida N,Bourguignon LYW,New CD44 splice variants asso ciated with human breast cancers.Cell Physiol,1995,102:127
  • 4Fukuse T,Hirata T,Naiki H,et al.Expression of proliferating cell nuclear antigen and cd44 variant isoforms in the primary and metastatic sites of non-small cell lung carcinoma with intrapulmonary metastases,Cancer.1999,86:1174
  • 5Salmi M,Gron VK,Sonitu P et al.Regulated expression of exon V6 containing isoforms of CD44 in man downregulation during malignant transformation of tumors of squamocellular origin.Cell Biol,1993,122:431
  • 6Ariza A,Mate JL,Isamat M,et al.Standard and variant CD44 isoforms are commonly expressed in lung cancer of the non-small cell type but not of the small cell type,Pathol,1995,177:363
  • 7Fasano M,Sabatini MT,Wieczorek R,et al.CD44 and its V6 spliced variant in lung tumors: a role in histogenesis? Cancer,1997,80:34
  • 8Mountain CF.Revisions in the international system for staging lung cancer.Chest,1997,111:710
  • 9Mountain CF,Dresler CM.Regional lymph node classification for lung cancer staging.Chest,1997,111:718
  • 10Hynes BF,Tien MJ,Patton KL,et al.CD44:a molecule involved in leukocyte adherence and T-cell activation.Immunol Today,1989,10:423

共引文献39

同被引文献45

  • 1Sokol SY. Spatial and temporal aspects of Wnt signaling and pla- nar cell polarity during vertebrate embryonic development [ J ]. Se- min Cell Dev Biol,2015 :Epub ahead of prim.
  • 2Badiglian Filho L, Oshima CT, De Oliveira Lima F, et al. Canoni- cal and noncanonical Wnt pathway : a comparison among normal ovary,benign ovarian tumor and ovarian cancer [ J ]. Oncol Re- ports,2009,21 (2) :313 - 320.
  • 3Bodnar L, Stanczak A, Cierniak S, et al. Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer[ J]. J Ovarian Res ,2014,7 : 16.
  • 4Enzo MV, Rastrelli M, Rossi CR, et al. The Wnt/β-catenin path- way in human fibrotic-like diseases and its eligibility as a thera- peutic target[ J]. Mol Cell Ther,2015,3 : 1.
  • 5VanhoUebeke B,Stone OA,BostaiUe N,et al. Tip cell-specific re- quirement for an atypical Gpr124-and Reck-dependent Wnt/βcate- nin pathway during brain angiogenesis[ J ]. Elife ,2015 ,4 :06489.
  • 6He L1, Lu N, Dai Q, et al. Wogonin induced G1 cell cycle arrest by regulating Wnt/β-catenin signaling pathway and inactivating CDK8 in human colorectal cancer carcinoma cells [ J ]. Toxicolo- gy,2013,312:36 -47.
  • 7Jayaraj P,Sen S,Sharma A,et al. Eyelid sebaceous carcinoma: a novel mutation in lymphoid enhancer-binding factor 1 ( LEF1 ) [J]. Br J Dermatol,2015 :Epub ahead of print.
  • 8Behrens J,Lustjg B. The wnt connection to tumorigenesis[ J]. Int J Dev Biol,200d,48(5 -6) :d77 -487.
  • 9Friedel Nollet,Geert Berx,Francis Molemans,Frans van Roy.Genomic Organization of the Human β-Catenin Gene (CTNNB1)[J].Genomics.1996(3)
  • 10Botkjaer KA,Deryugina EI,Dupont DM,et al.Targeting tumor cell invasion and dissemination in vivo by an aptamer that inhibits urokinase-type plasminogen activator through a novel multifunctional mechanism[J].Molecular Cancer Research,2012,10(12):1532-1543.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部